missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18543125

Semaphorin 4D/CD100 Antibody (547412), DyLight 680, Novus Biologicals™

Rat Monoclonal Antibody

Brand:  Novus Biologicals FAB52351Y

Product Code. 18543125

  • 594.00€ / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Semaphorin 4D/CD100 Monoclonal antibody specifically detects Semaphorin 4D/CD100 in Mouse samples. It is validated for Flow Cytometry, CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Semaphorin 4D/CD100
Monoclonal
DyLight 680
50mM Sodium Borate
Rat
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Mouse
Purified
Flow Cytometry, CyTOF
547412
Flow Cytometry, CyTOF-ready
A8, CD100 antigen, CD100M-sema-G, coll-4, FLJ33485, FLJ34282, FLJ39737, FLJ46484, immunoglobulin domain (Ig), transmembrane domain (TM) and shortcytoplasmic domain, 4D, MGC169138, MGC169141, sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and shortcytoplasmic domain, (semaphorin) 4D, semaphorin-4D
Mouse myeloma cell line NS0-derived recombinant mouse Semaphorin 4D/CD100, Phe24-Thr657, Accession # NP_038688
0.1 mL
Apoptosis, Immunology
10507
Store at 4°C in the dark.
IgG2b
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.